We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nasopharyngeal Pneumococcal Density Associated with Invasive Lung Disease

By LabMedica International staff writers
Posted on 30 Oct 2019
Print article
Image: A three-dimensional (3D) computer-generated image of a group of Gram-positive, Streptococcus pneumoniae bacteria that cause invasive pneumococcal disease. The artistic recreation was based upon scanning electron microscopic (SEM) imagery (Photo courtesy of Dan Higgins/US Centers of Disease Control and Prevention).
Image: A three-dimensional (3D) computer-generated image of a group of Gram-positive, Streptococcus pneumoniae bacteria that cause invasive pneumococcal disease. The artistic recreation was based upon scanning electron microscopic (SEM) imagery (Photo courtesy of Dan Higgins/US Centers of Disease Control and Prevention).
Streptococcus pneumoniae (pneumococcus) is one of the most important bacterial causes of pneumonia among children and adults worldwide. Nasopharyngeal pneumococcal colonization is common in young children and represents a critical initial step in the progression to invasive disease.

Increases in the density of pneumococci in the nasopharynx have been associated with the onset of respiratory illness and might also play a role in transmission of bacteria to others. Respiratory viruses are frequently detected in the nasopharynx of young children during asymptomatic periods.

An international team of scientists working with the Vanderbilt University Medical Center (Nashville, TN, USA) enrolled children less than 3 years of age, residing in the Peruvian study area, who were prospectively assessed for acute respiratory illness (ARI) symptoms during weekly household visits. An ARI episode was defined as the presence of either cough or fever and the team considered a child to be asymptomatic if the child had rhinorrhea alone or no ARI symptoms.

The investigators collected nasopharyngeal swabs from each child monthly, whether or not ARI symptoms were present, and tested the swabs by bacterial culture for pneumococcal identification and quantitative polymerase chain reaction (qPCR) for pneumococcal density determinations. A subset of nasopharyngeal samples were collected during asymptomatic periods underwent real-time reverse transcription PCR (rRT-PCR) viral testing or influenza virus (types A, B, and C), respiratory syncytial virus (RSV), human metapneumovirus (MPV), rhinovirus (HRV), adenovirus (AdV), and parainfluenza virus (PIV) types 1–3.

The team reported that a total, 849 nasopharyngeal samples collected during asymptomatic periods from 480 children underwent both viral testing and pneumococcal density determinations. Pneumococcus was detected in 566/849 (67%) nasopharyngeal samples from asymptomatic children. At least one respiratory virus was detected in 357/849 (42%) samples from asymptomatic children, most commonly HRV (31%) and AdV (11%), whereas detections of influenza, MPV, PIV, and RSV in asymptomatic children were uncommon (<3%).

Total pneumococcal densities (encompassing all present serotypes) during asymptomatic periods were significantly higher when a respiratory virus was detected versus when no virus was detected. In adjusted analyses, increased pneumococcal density was significantly associated with the risk for a subsequent ARI, whereas asymptomatic viral detection alone was associated with lower risk for subsequent ARI.

The authors concluded that viral detections during asymptomatic periods are associated with increases in nasopharyngeal pneumococcal colonization density. Furthermore, they found that pneumococcal density, especially at high levels, is associated with subsequent development of ARI in young children in Peru. These findings suggest that interactions between viruses and pneumococci in the nasopharynx during asymptomatic periods might have a role in onset of subsequent ARI. The study was published on October 15, 2019, in the journal Emerging Infectious Diseases.

Related Links:
Vanderbilt University Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.